Business Wire

Emulate, Inc. Unveils the Chip-R1™ Rigid Chip with a Minimally Drug-Absorbing Profile to Improve Biological Modeling for ADME and Toxicology Applications

BOSTON--(BUSINESS WIRE)--Emulate, Inc., the leading provider of next-generation in vitro Organ-Chip models, today announced the release of its new Chip-R1™ Rigid Chip, designed to minimize drug ...
MarketWatch

Emulate Applauds FDA's Roadmap to Reduce Animal Testing and Embrace Organ-Chip Technologies

Emulate, Inc., a leading provider of next-generation in vitro models, today welcomed the U.S. Food and Drug Administration's (FDA) newly announced plan to reduce reliance on animal testing in ...
Technology Networks

Industrializing Organ-on-a-Chip Technology

Can organ-on-a-chip technology solve drug development’s biggest challenge—poor clinical success rates? Dr. Lorna Ewart ...
GEN

In Vitro Human Models Grow Up

For decades, animal models have been the gold standard for preclinical testing of potential drugs. Yet, even the best animal models are not perfect. For example, small rodent species with engrafted ...
Reuters

Seres, Emulate collaborate to advance Emulate's intestine-chip platform

* Seres and Emulate will work to advance Emulate's intestine-chip platform, a living-tissue-based system that models human intestine ...
Nature

Is the FDA’s plan to phase out animal toxicity testing realistic?

Lorna Ewart has long been frustrated by the mismatch between animal and human toxicity data. All too often preclinical studies in rats and dogs will suggest a drug is safe, only for clinical trial ...